Doctorsa Secures €1M to Propel Global Traveler Health Platform
July 15, 2026, 9:32 am
Doctorsa, the innovative digital health platform for international travelers, has successfully secured €1 million in new funding. PranaVentures led this significant investment round. The fresh capital will drive aggressive global expansion, with a prime focus on the lucrative United States market. Doctorsa also plans to launch a comprehensive B2B offering. The platform already links over 250,000 travelers with 550 doctors across 40 nations, providing rapid, English-language video consultations. It pioneers AI-powered 'Agentic Booking' for seamless medical appointments. This strategic funding positions Doctorsa to capitalize on surging international travel and the increasing demand for accessible, immediate digital healthcare solutions worldwide.
Milan-based Doctorsa closed a €1 million investment round. This capital infusion will fuel aggressive international growth. PranaVentures spearheaded the funding. Vento and 40Jemz Ventures also participated. The platform specializes in digital healthcare for global travelers. Doctorsa aims to redefine urgent care access abroad.
Doctorsa plans strategic market consolidation. It seeks accelerated international expansion. A new B2B offering is also in development. This targets companies, insurance providers, and tourism operators. The company, founded by Nadia Neytcheva and Francesco Maria Serino, rebranded to Doctorsa in 2023. It has since supported over 250,000 travelers. Doctorsa stands as a key player in telehealth for international travel.
The Doctorsa service connects international travelers with medical professionals. Its network includes 550 doctors. These doctors span 40 different countries. Users describe their health issue. They then view available doctors in their current location. A doctor match occurs rapidly, typically within five minutes. Video consultations follow immediately. These consultations are available in English. Prices begin at €20. This makes global medical care transparent and accessible.
The model requires no subscriptions. No prior registration is necessary. The focus is direct, on-demand care. Consultations can include clinical support. Medical prescriptions are provided when appropriate. This depends on local regulations and professional assessment. Doctorsa addresses a critical need. It targets urgent care during international travel. Travelers often struggle with unfamiliar healthcare systems. Language barriers pose significant challenges. Finding the right medical facility quickly becomes complex. Doctorsa simplifies this process, offering immediate telemedicine solutions.
A substantial portion of the new investment targets the United States. US citizens already represent 40% of Doctorsa's patient base. This strong user engagement drives the strategic focus. The American market is a primary growth area for digital health innovation. Doctorsa’s strategy extends beyond individual users. It involves key partnerships. Collaborations with tour operators are planned. Travel platforms, insurance companies, and businesses are also targets. These partnerships aim to integrate digital health services. Doctorsa wants to embed its offerings into existing travel packages.
The platform can integrate into corporate welfare programs. This ensures employee assistance abroad. Employees who travel or work frequently overseas will benefit. This provides robust digital healthcare support. It enhances peace of mind for global workforces. The B2B model provides scalable solutions. It expands Doctorsa's reach significantly, solidifying its position in travel health.
Doctorsa is pioneering artificial intelligence integration. The company developed a proprietary Agentic Booking system. This innovation enters the digital health sector. It allows users to find and book medical visits. Users interact directly through their preferred AI assistant. The system uses open-standard interfaces. Crucially, the user retains final booking control. The AI assistant manages operational steps. The user confirms the doctor choice and consultation.
This model brings agentic commerce to healthcare. Agentic commerce is growing rapidly in the travel sector. It delegates tasks to AI agents. These tasks include research, comparison, and service booking. Doctorsa applies this efficiency to medical appointments. It streamlines access to care. It puts control in the hands of the traveler. This represents a significant leap in convenience for global medical access.
The medical system has historically required patient adaptation. Doctorsa believes the opposite should be true. Healthcare must adapt to people's needs. Seamless access to a doctor should be a natural part of travel. Complex searches during a health crisis should be avoided. The platform's rapid growth proves this demand. Users seek cost transparency. They want quick response times. Freedom of choice in healthcare is paramount. These elements are vital for modern patient experiences.
The PranaVentures support will expand this model. Doctorsa will pursue partnerships. These include companies, insurers, tour operators, and global platforms. Doctorsa will also invest in infrastructure development. This infrastructure will communicate directly with AI assistants. This commitment ensures continued technological leadership in AI-driven healthcare.
This investment marks PranaVentures’ 20th through its first fund. The firm’s portfolio shows strong performance. It boasts three successful exits in less than five years. Doctorsa operates in a sector with robust structural trends. These include the growth of international tourism. The evolution of telemedicine is another key trend. Demand for accessible, immediate digital health services is rising. This confluence of factors creates a powerful market for Doctorsa.
PranaVentures recognized Doctorsa’s capabilities. The company built a scalable platform. It established a distinctive international position. This investment aligns with PranaVentures’ "Future of Health" strategy. The fund plans increased commitment to this vertical. Launched in 2021, PranaVentures has €40 million in subscribed capital. It invests in seed-stage digital and tech startups. A new fund, Prana101, targets €100 million.
Doctorsa’s growth coincides with expanding international mobility. Digital-first healthcare services are also booming. International travel exceeded 1.5 billion trips in 2025. This figure comes from UN Tourism data. Increased tourist flows drive demand for remote healthcare. This is especially true for urgent issues. Many problems require rapid assessment. They do not always necessitate emergency room visits. Telemedicine offers the perfect solution.
The platform also creates new professional channels for doctors. They can conduct remote consultations flexibly. The recent funding round must translate user volume into broader international presence. It must secure B2B agreements. The goal is to make the service an integral part of the travel experience. Doctorsa positions itself at the forefront of this transformation. It ensures health security for travelers globally. This solidifies its role in the future of travel and digital health.
Milan-based Doctorsa closed a €1 million investment round. This capital infusion will fuel aggressive international growth. PranaVentures spearheaded the funding. Vento and 40Jemz Ventures also participated. The platform specializes in digital healthcare for global travelers. Doctorsa aims to redefine urgent care access abroad.
Doctorsa plans strategic market consolidation. It seeks accelerated international expansion. A new B2B offering is also in development. This targets companies, insurance providers, and tourism operators. The company, founded by Nadia Neytcheva and Francesco Maria Serino, rebranded to Doctorsa in 2023. It has since supported over 250,000 travelers. Doctorsa stands as a key player in telehealth for international travel.
The Doctorsa service connects international travelers with medical professionals. Its network includes 550 doctors. These doctors span 40 different countries. Users describe their health issue. They then view available doctors in their current location. A doctor match occurs rapidly, typically within five minutes. Video consultations follow immediately. These consultations are available in English. Prices begin at €20. This makes global medical care transparent and accessible.
The model requires no subscriptions. No prior registration is necessary. The focus is direct, on-demand care. Consultations can include clinical support. Medical prescriptions are provided when appropriate. This depends on local regulations and professional assessment. Doctorsa addresses a critical need. It targets urgent care during international travel. Travelers often struggle with unfamiliar healthcare systems. Language barriers pose significant challenges. Finding the right medical facility quickly becomes complex. Doctorsa simplifies this process, offering immediate telemedicine solutions.
A substantial portion of the new investment targets the United States. US citizens already represent 40% of Doctorsa's patient base. This strong user engagement drives the strategic focus. The American market is a primary growth area for digital health innovation. Doctorsa’s strategy extends beyond individual users. It involves key partnerships. Collaborations with tour operators are planned. Travel platforms, insurance companies, and businesses are also targets. These partnerships aim to integrate digital health services. Doctorsa wants to embed its offerings into existing travel packages.
The platform can integrate into corporate welfare programs. This ensures employee assistance abroad. Employees who travel or work frequently overseas will benefit. This provides robust digital healthcare support. It enhances peace of mind for global workforces. The B2B model provides scalable solutions. It expands Doctorsa's reach significantly, solidifying its position in travel health.
Doctorsa is pioneering artificial intelligence integration. The company developed a proprietary Agentic Booking system. This innovation enters the digital health sector. It allows users to find and book medical visits. Users interact directly through their preferred AI assistant. The system uses open-standard interfaces. Crucially, the user retains final booking control. The AI assistant manages operational steps. The user confirms the doctor choice and consultation.
This model brings agentic commerce to healthcare. Agentic commerce is growing rapidly in the travel sector. It delegates tasks to AI agents. These tasks include research, comparison, and service booking. Doctorsa applies this efficiency to medical appointments. It streamlines access to care. It puts control in the hands of the traveler. This represents a significant leap in convenience for global medical access.
The medical system has historically required patient adaptation. Doctorsa believes the opposite should be true. Healthcare must adapt to people's needs. Seamless access to a doctor should be a natural part of travel. Complex searches during a health crisis should be avoided. The platform's rapid growth proves this demand. Users seek cost transparency. They want quick response times. Freedom of choice in healthcare is paramount. These elements are vital for modern patient experiences.
The PranaVentures support will expand this model. Doctorsa will pursue partnerships. These include companies, insurers, tour operators, and global platforms. Doctorsa will also invest in infrastructure development. This infrastructure will communicate directly with AI assistants. This commitment ensures continued technological leadership in AI-driven healthcare.
This investment marks PranaVentures’ 20th through its first fund. The firm’s portfolio shows strong performance. It boasts three successful exits in less than five years. Doctorsa operates in a sector with robust structural trends. These include the growth of international tourism. The evolution of telemedicine is another key trend. Demand for accessible, immediate digital health services is rising. This confluence of factors creates a powerful market for Doctorsa.
PranaVentures recognized Doctorsa’s capabilities. The company built a scalable platform. It established a distinctive international position. This investment aligns with PranaVentures’ "Future of Health" strategy. The fund plans increased commitment to this vertical. Launched in 2021, PranaVentures has €40 million in subscribed capital. It invests in seed-stage digital and tech startups. A new fund, Prana101, targets €100 million.
Doctorsa’s growth coincides with expanding international mobility. Digital-first healthcare services are also booming. International travel exceeded 1.5 billion trips in 2025. This figure comes from UN Tourism data. Increased tourist flows drive demand for remote healthcare. This is especially true for urgent issues. Many problems require rapid assessment. They do not always necessitate emergency room visits. Telemedicine offers the perfect solution.
The platform also creates new professional channels for doctors. They can conduct remote consultations flexibly. The recent funding round must translate user volume into broader international presence. It must secure B2B agreements. The goal is to make the service an integral part of the travel experience. Doctorsa positions itself at the forefront of this transformation. It ensures health security for travelers globally. This solidifies its role in the future of travel and digital health.